Google LLC has reached a preliminary settlement for its consumer privacy lawsuit. The tech giant owned by Alphabet Inc. agreed to settle and expected to shell out at least $5 billion for the case.
Trial Date for Formal Settlement Has Been Set
The lawsuit is related to the lawsuit that alleged Google has secretly tracked the internet use of millions of users who have always believed they were browsing the web privately. On Thursday, Dec. 28, U.S. District Judge Yvonne Gonzalez Rogers, in Oakland, California, scheduled the trial on the proposed class action suit against the company on Feb. 5, 2024.
The judge set the date after the respective lawyers of Google and the consumers revealed they were able to settle. As per Reuters, the plaintiffs are seeking at least $5 billion, but the legal representatives of both sides did not disclose the exact agreed terms of the settlement.
The Allegations Against Google
Then again, while Google and the lawyers declined to comment on the settlement, Forbes reported that the central point of the lawsuit is to put the tech firm's transparency under scrutiny. This is because the case is based on the premise that Google's analytics and ad-targeting mechanisms continued to extract and collect personal data even if the user privacy settings were set to private.
Meanwhile, the case was initially filed in 2020, covering millions of Google users since June 1, 2016. Each user has been seeking at least $5,000 in damages for their claims of violations of federal wire-tapping laws and the California privacy laws. The lawsuit is being tried under the name Brown et al. v Google LLC et al., U.S. District Court, Northern District of California, with case file No. 20-03664.
Photo by: Kai Wenzel/Unsplash


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



